Stroke
Conditions
Interventions
Control:Bayaspirin Enteric-coated 100mg/day
Experimental:Bayaspirin Enteric-coated 100mg/day + Naonuotong
Sponsors
The First Affiliated Hospital of Anhui traditional Chinese Medicine University
Eligibility
Sex/Gender
Male
Age
37 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) at the age of 37-80; (2) consistent with ischemic stroke (cerebral infarction) diagnostic criteria of TCM syndrome differentiation of apoplexy, deficiency of Qi and blood stasis are the genus; (3) patients 14 to 6 months after onset of stroke; (4) signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) transient ischemic attack (TIA); (2) nearly 6 months since a brain hemorrhage; (3) on the components of drug allergy and allergic; (4) confirmed by brain tumor, brain injury, blood disease caused by stroke patients; (5) had previous stroke history and legacy have serious symptoms, curative effect evaluation; (6) the patients with severe heart disease, heart failure, liver dysfunction, renal dysfunction, respiratory failure, malignant tumor, gastrointestinal hemorrhage is expected to not complete follow-up of 1 years; (7) patients with mental disease; (8) other reasons can not be timely medication; (9) in pregnant and lactating women; (10) participating in other clinical trials of patients; (11) researchers think of other reasons not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIH Stroke Scale;The Barthel index;The modified Rankin scale;TCM syndrome change;Blood rheology; | — |
Countries
China
Contacts
Public ContactYang Wenming
Outcome results
None listed